Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA
Beyfortus study shows sustained reduction in infant RSV hospitalisations across two seasons
I Peace generates human iPS cells from NKT cells and offers them for research use
Roivant to announce Q3 2026 financial results
Blacksmith Medicines granted European patent for LpxC-targeting antibacterial compounds
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
Merck KGaA to acquire JSR Life Sciences chromatography business to expand Protein A capabilities
60 Degrees reports first patient has tested negative for babesiosis in tafenoquine study